MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijrobp.2016.12.028

Медицинская библиотека · International journal of radiation oncology, biology, physics · 2016

Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN).

Koto Masashi, Demizu Yusuke, Saitoh Jun-Ichi, Suefuji Hiroaki, Tsuji Hiroshi, Okimoto Tomoaki, Ohno Tatsuya, Shioyama Yoshiyuki, Takagi Ryo, Nemoto Kenji, Nakano Takashi, Kamada Tadashi, Japan Carbon-Ion Radiation Oncology Study Group

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

PURPOSE: To evaluate the efficacy and safety of carbon-ion radiation therapy (RT) for mucosal melanoma of the head and neck (MMHN) in the Japan Carbon-Ion Radiation Oncology Study Group study.

METHODS AND MATERIALS: Patients with MMHN with N0-1M0 status who were treated with carbon-ion RT at 4 institutions in Japan between November 2003 and December 2014 were analyzed retrospectively. Two hundred sixty patients (male, 111; female, 149; median age, 68 years) with histologically proven MMHN were enrolled.

RESULTS

Primary sites included the nasal cavity in 178 patients, paranasal sinuses in 43, oral cavity in 27, and pharynx in 12. Eighty-six patients had T3 tumors, 147 had T4a tumors, and 27 had T4b tumors. Two hundred fifty-one patients were diagnosed with N0 disease, and 9 with N1 disease. The median total dose and number of fractions were 57.6 Gy RBE (relative biological effectiveness) and 16, respectively. Chemotherapy including dimethyl traizeno imidazole carboxamide was used concurrently in 129 patients. The median follow-up duration was 22 months (range, 1-132 months). The 2-year overall survival and local control rates were 69.4% and 83.9%, respectively. Multivariate analysis showed that gross tumor volume and concurrent chemotherapy were significant prognostic factors for overall survival. Grade 3 and grade 4 late morbidities were observed in 27 and 7 patients (5 developed ipsilateral blindness, 1 mucosal ulcer, and 1 second malignant disease in the irradiated volume), respectively. No patients developed grade 5 late morbidities.

CONCLUSION

Carbon-ion RT is a promising treatment option for MMHN.

Для цитирования: Koto Masashi, Demizu Yusuke, Saitoh Jun-Ichi, Suefuji Hiroaki, Tsuji Hiroshi, Okimoto Tomoaki, Ohno Tatsuya, Shioyama Yoshiyuki, Takagi Ryo, Nemoto Kenji, Nakano Takashi, Kamada Tadashi, Japan Carbon-Ion Radiation Oncology Study Group. Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN).. International journal of radiation oncology, biology, physics. 2016. DOI: 10.1016/j.ijrobp.2016.12.028.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.